Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development

被引:94
|
作者
Hoch, RV [1 ]
Soriano, P [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Program Dev Biol, Seattle, WA 98109 USA
来源
DEVELOPMENT | 2006年 / 133卷 / 04期
关键词
Fgfr1; Frs2; Frs3; signaling; gastrulation; neural tube; tail bud; pharyngeal arches;
D O I
10.1242/dev.02242
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fibroblast growth factor receptor 1 (Fgfr1) plays pleiotropic roles during embryonic development, but the mechanisms by which this receptor signals in vivo have not previously been elucidated. Biochemical studies have implicated Fgf receptor-specific substrates (Frs2, Frs3) as the principal mediators of Fgfr1 signal transduction to the MAPK and PI3K pathways. To determine the developmental requirements for Fgfr1-Frs signaling, we generated mice (Fgfr1(Delta Frs/Delta Frs)) in which the Frs2/3-binding site on Fgfr1 is deleted. Fgfr1(Delta Frs/Delta Frs) embryos die during late embryogenesis, and exhibit defects in neural tube closure and in the development of the tail bud and pharyngeal arches. However, the mutant receptor is able to drive Fgfr1 functions during gastrulation and somitogenesis, and drives normal MAPK responses to Fgf. These findings indicate that Fgfr1 uses distinct signal transduction mechanisms in different developmental contexts, and that some essential functions of this receptor are mediated by Frs-independent signaling.
引用
收藏
页码:663 / 673
页数:11
相关论文
共 21 条
  • [1] Context-specific requirements for FRS2-mediated signaling downstream of FGFR1 during mouse development.
    Hoch, RV
    Soriano, P
    DEVELOPMENTAL BIOLOGY, 2005, 283 (02) : 593 - 593
  • [2] Genomic organization and comparative sequence analysis of the mouse and human FRS2, FRS3 genes
    Li Zhou
    Kathryn McDougall
    Christopher J. Kubu
    Joseph M. Verdi
    Susan O. Meakin
    Molecular Biology Reports, 2003, 30 : 15 - 25
  • [3] Genomic organization and comparative sequence analysis of the mouse and human FRS2, FRS3 genes
    Zhou, L
    McDougall, K
    Kubu, CJ
    Verdi, JM
    Meakin, SO
    MOLECULAR BIOLOGY REPORTS, 2003, 30 (01) : 15 - 25
  • [4] Ureteric Morphogenesis Requires Fgfr1 and Fgfr2/Frs2α Signaling in the Metanephric Mesenchyme
    Sims-Lucas, Sunder
    Di Giovanni, Valeria
    Schaefer, Caitlin
    Cusack, Brian
    Eswarakumar, Veraragavan P.
    Bates, Carlton M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (04): : 607 - 617
  • [5] Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2α (FRS2α) but not FRS2β to the receptor
    Zhang, Yongyou
    McKeehan, Kerstin
    Lin, Yongshun
    Zhang, Jue
    Wang, Fen
    MOLECULAR ENDOCRINOLOGY, 2008, 22 (01) : 167 - 175
  • [6] Neurotrophin and FGF Signaling Adapter Proteins, FRS2 and FRS3, Regulate Dentate Granule Cell Maturation and Excitatory Synaptogenesis
    Nandi, Sayan
    Alvina, Karina
    Lituma, Pablo J.
    Castillo, Pablo E.
    Hebert, Jean M.
    NEUROSCIENCE, 2018, 369 : 192 - 201
  • [7] The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
    Ho, Thai H.
    Liu, Xian-De
    Huang, Yanqing
    Warneke, Carla L.
    Johnson, Marcella M.
    Hoang, Anh
    Tamboli, Pheroze
    Wang, Fen
    Jonasch, Eric
    BMC CANCER, 2015, 15
  • [8] EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2
    Wu, YJ
    Chen, ZJ
    Ullrich, A
    BIOLOGICAL CHEMISTRY, 2003, 384 (08) : 1215 - 1226
  • [9] The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
    Thai H Ho
    Xian-De Liu
    Yanqing Huang
    Carla L Warneke
    Marcella M Johnson
    Anh Hoang
    Pheroze Tamboli
    Fen Wang
    Eric Jonasch
    BMC Cancer, 15
  • [10] Unique role of SNT-2/FRS2β/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways
    L Huang
    M Watanabe
    M Chikamori
    Y Kido
    T Yamamoto
    M Shibuya
    N Gotoh
    N Tsuchida
    Oncogene, 2006, 25 : 6457 - 6466